Look for:

Products

AMGEN INC.


ISIN:
US0311621009
WKN:
031162100

2021/03/01 22:00:00
Price
227.04 USD
Difference 0.94% (2.12)

General attributes

ISINUS0311621009
SymbolAMGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)108,480 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)226.95 USD (100)
Ask (Ask size)227.80 USD (200)
Open225.88 USD
High227.9289 USD
Low225.23 USD
Close (prev. day)224.92 USD
VWAP227.043591 USD
Volume (pcs)2,178,149
Trading volume494,556,018.92
Number of trades34,174
Last size418,128

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: AMGEN INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2021/03/01 22:00:00
Price
227.04 USD
Difference 0.94% (2.12)

General attributes

ISINUS0311621009
SymbolAMGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)108,480 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)226.95 USD (100)
Ask (Ask size)227.80 USD (200)
Open225.88 USD
High227.9289 USD
Low225.23 USD
Close (prev. day)224.92 USD
VWAP227.043591 USD
Volume (pcs)2,178,149
Trading volume494,556,018.92
Number of trades34,174
Last size418,128

Performance and Risk

6m1Y3Y
Perf (%)-9.50%+13.67%+23.87%
Perf (abs.)-23.82+27.31+43.75
Beta0.820.760.80
Volatility25.5937.3628.45
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)228.39 USD (2,800,167)
Ø price 30 days | Ø volume 30 days (pcs.)239.67 USD (2,565,139)
Ø price 100 days | Ø volume 100 days (pcs.)233.03 USD (2,550,932)
Ø price 250 days | Ø volume 250 days (pcs.)233.17 USD (2,797,201)
YTD High | date276.69 USD (2021/01/28)
YTD Low | date223.62 USD (2021/02/26)
52 Weeks High | date276.69 USD (2021/01/28)
52 Weeks Low | date177.05 USD (2020/03/23)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2021/03/0117:35188.62 EUR0.55141
Vienna Stock Exchange2021/03/0117:32188.58 EUR0.0815
Tradegate2021/03/0122:26188.60 EUR0.2138
Stuttgart2021/03/0118:10188.56 EUR0.005
SIX Swiss Exchange2019/06/2717:35184.90 CHF0.002
Nasdaq2021/03/0122:00227.04 USD494.5634,174
Munich2021/03/0108:02187.40 EUR0.001
London Stock Exchange2021/03/0117:35227.025 USD0.002
Hong Kong Stock Exchange2021/02/1102:201,761.00 HKD--
Hanover2021/03/0109:44188.44 EUR0.002
Hamburg2021/03/0109:54188.96 EUR0.042
Frankfurt2021/03/0117:20188.36 EUR0.035
Duesseldorf2021/03/0119:00188.08 EUR0.0017
Borsa Italiana MTF Trading After Hours2021/01/1218:12194.86 EUR0.001
Borsa Italiana MTF Global Equity Market2021/03/0117:35184.92 EUR0.001
Berlin2021/03/0108:08187.44 EUR0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=1823&ID_TYPE_IMAGE_LOGO=2

Contact Details

AMGEN, INC.
- -
One Amgen Center Drive - 91320-1799 Thousand Oaks
Telefon: 1-805-447-1000
Fax: 1-805-447-1010
E-mail: -

PDF Downloads

Company report: AMGEN INC.PDF Download

Company Profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Members of Management Board

Brian DrukerMember of Board of Directors
Robert WilliamsMember of Board of Directors
Ronald SugarMember of Board of Directors
Tyler JacksMember of Board of Directors
Wanda AustinMember of Board of Directors
Amy MilesMember of Board of Directors
Charles HolleyMember of Board of Directors
Ellen KullmanMember of Board of Directors
Fred HassanMember of Board of Directors
Greg GarlandMember of Board of Directors
Robert EckertMember of Board of Directors
Robert BradwayChairman of Managing Board
Darryl SleepMember of Executive Committee
David ReeseMember of Executive Committee
Elliott LevyMember of Executive Committee
Paul EisenbergMember of Executive Committee
Steven GalsonMember of Executive Committee
Arvind SoodMember of Executive Committee
David MelineMember of Executive Committee
David PiacquadMember of Executive Committee
Esteban SantosMember of Executive Committee
Gregory FribergMember of Executive Committee
Janet CheethamMember of Executive Committee
Jonathan GrahamMember of Executive Committee
Linda LouieMember of Executive Committee






Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.